Authors:
Long, YQ
Lee, SL
Lin, CY
Enyedy, IJ
Wang, SM
Li, P
Dickson, RB
Roller, PP
Citation: Yq. Long et al., Synthesis and evaluation of the sunflower derived trypsin inhibitor as a potent inhibitor of the type II transmembrane serine protease, matriptase, BIOORG MED, 11(18), 2001, pp. 2515-2519
Citation: Cm. Benaud et Rb. Dickson, Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc, ONCOGENE, 20(33), 2001, pp. 4554-4567
Authors:
Holst-Hansen, C
Low, JA
Stephens, RW
Johnson, MD
Carmeliet, P
Frandsen, TL
Brunner, N
Dickson, RB
Citation: C. Holst-hansen et al., Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat, BREAST CANC, 68(3), 2001, pp. 225-237
Authors:
Enyedy, IJ
Lee, SL
Kuo, AH
Dickson, RB
Lin, CY
Wang, SM
Citation: Ij. Enyedy et al., Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase, J MED CHEM, 44(9), 2001, pp. 1349-1355
Citation: C. Benaud et al., Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor, EUR J BIOCH, 268(5), 2001, pp. 1439-1447
Authors:
Oberst, M
Anders, J
Xie, B
Singh, B
Ossandon, M
Johnson, M
Dickson, RB
Lin, CY
Citation: M. Oberst et al., Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo, AM J PATH, 158(4), 2001, pp. 1301-1311
Citation: Mh. Jamerson et al., Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models, ONCOGENE, 19(8), 2000, pp. 1065-1071
Authors:
Liao, DJ
Natarajan, G
Deming, SL
Jamerson, MH
Johnson, M
Chepko, G
Dickson, RB
Citation: Dj. Liao et al., Cell cycle basis for the onset and progression of c-Myc-induced, TGF alpha-enhanced mouse mammary gland carcinogenesis, ONCOGENE, 19(10), 2000, pp. 1307-1317
Citation: Sl. Lee et al., Activation of hepatocyte growth factor and urokinase/plasminogen activatorby matriptase, an epithelial membrane serine protease, J BIOL CHEM, 275(47), 2000, pp. 36720-36725
Citation: Sl. Deming et al., C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance, BR J CANC, 83(12), 2000, pp. 1688-1695
Authors:
Weaver, ZA
McCormack, SJ
Liyanage, M
du Manoir, S
Coleman, A
Schrock, E
Dickson, RB
Ried, T
Citation: Za. Weaver et al., A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice, GENE CHROM, 25(3), 1999, pp. 251-260
Citation: Cy. Lin et al., Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity, J BIOL CHEM, 274(26), 1999, pp. 18231-18236
Citation: Cy. Lin et al., Purification and characterization of a complex containing matriptase and aKunitz-type serine protease inhibitor from human milk, J BIOL CHEM, 274(26), 1999, pp. 18237-18242
Authors:
Rosfjord, EC
Maemura, M
Johnson, MD
Torri, JA
Akiyama, SK
Woods, VL
Dickson, RB
Citation: Ec. Rosfjord et al., Activation of protein kinase C by phorbol esters modulates alpha(2)beta(1)integrin on MCF-7 breast cancer cells, EXP CELL RE, 248(1), 1999, pp. 260-271
Authors:
Johnson, MD
Torri, JA
Lippman, ME
Dickson, RB
Citation: Md. Johnson et al., Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness, EXP CELL RE, 247(1), 1999, pp. 105-113
Citation: Ec. Rosfjord et Rb. Dickson, Application of flow cytometry in the analysis and sterile sorting of cell populations based on integrin expression, METH MOL B, 129, 1999, pp. 79-90